Inicio Zine News CinDome Pharma Announces Start of Phase 2 Trial of Deuterated Domperidone (CIN-102)

CinDome Pharma Announces Start of Phase 2 Trial of Deuterated Domperidone (CIN-102)

8
0
CinDome Pharma, a biotech company focusing on gastrointestinal compounds, is developing CIN-102 for the treatment of gastroparesis
CinDome Pharma, a biotech company focusing on gastrointestinal compounds, is developing CIN-102 for the treatment of gastroparesis